EUVIMEDEUVIMED entdecken
Crossref

Activation of β3-adrenergic receptor by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue

Ze-Bei Zhang, Yu-Wen Cheng, Lian Xu, Jia-Qi Li, Xin Pan, Min Zhu, Xiao-Hui Chen, Ai-Jun Sun, Jing-Rong Lin iD, Ping-Jin Gao

Cardiovascular Research · 31.12.2024 · 120 (17) · 2307-2319

DOI: 10.1093/cvr/cvae213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 17.09.2024. Verfasst von Ze-Bei Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hyper…. Hauptthemen laut MEDLINE: Aortic Dissection, Lymphangiogenesis, Adrenergic beta-3 Receptor Agonists, Mice, Inbred C57BL. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, Shanghai Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims β3-Adrenergic receptor (β3-AR) is essential for cardiovascular homoeostasis through regulating adipose tissue function. Perivascular adipose tissue (PVAT) has been implicated in the pathogenesis of aortic dissection and aneurysm (AD/AA). Here, we aim to investigate β3-AR activation-mediated PVAT function in AD/AA. Methods and results Aortas from patients with thoracic aortic dissection (TAD) were collected to detect β3-AR expression in PVAT. ApoE−/− and β-aminopropionitrile monofumarate (BAPN)-treated C57BL/6 mice were induced with Angiotensin II (AngII) to simulate AD/AA and subsequently received either placebo or mirabegron, a β3-AR agonist. The results demonstrated an up-regulation of β3-AR in PVAT of TAD patients and AD/AA mice. Moreover, activation of β3-AR by mirabegron significantly prevented AngII-induced AD/AA formation in mice. RNA-sequencing analysis of adipocytes from PVAT revealed a notable increase of the lymphangiogenic factor, vascular endothelial growth factor C (VEGF-C), in mirabegron-treated mice. Consistently, enhanced lymphangiogenesis was found in PVAT with mirabegron treatment. Mechanistically, the number of CD4+/CD8+ T cells and CD11c+ cells was reduced in PVAT but increased in adjacent draining lymph nodes of mirabegron-treated mice, indicating the improved draining and clearance of inflammatory cells in PVAT by lymphangiogenesis. Importantly, adipocyte-specific VEGF-C knockdown by the adeno-associated virus system restrained lymphangiogenesis and exacerbated inflammatory cell infiltration in PVAT, which ultimately abolished the protection of mirabegron on AD/AA. In addition, the conditional medium derived from mirabegron-treated adipocytes activated the proliferation and tube formation of LECs, which was abrogated by the silencing of VEGF-C in adipocytes. Conclusion Our findings illustrated the therapeutic potential of β3-AR activation by mirabegron on AD/AA, which promoted lymphangiogenesis by increasing adipocyte-derived VEGF-C and, therefore, ameliorated PVAT inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic DissectionLymphangiogenesisAdrenergic beta-3 Receptor AgonistsMice, Inbred C57BLReceptors, Adrenergic, beta-3AcetanilidesVascular Endothelial Growth Factor CDisease Models, AnimalAdipose TissueAortic Aneurysm, ThoracicMice, Knockout, ApoEThiazolesAnimalsHumansMaleSignal TransductionAorta, ThoracicAngiotensin IIAdipocytesCells, CulturedMiceLymphatic VesselsFemaleMiddle Aged

Stichwörter der Autor:innen

Adipocyte-derived VEGF-CAortic dissection/aneurysmLymphangiogenesisMirabegronβ3-AR

Substanzen

mirabegronAdrenergic beta-3 Receptor AgonistsReceptors, Adrenergic, beta-3AcetanilidesVascular Endothelial Growth Factor CThiazolesvascular endothelial growth factor C, mouseAngiotensin IIAdrb3 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medi…
  • Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Gerontology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.

ORCID-Profile: Jing-Rong Lin

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission
  • Shanghai Science and Technology Commission

Zitieren

APA

Zhang, Z. B., Cheng, Y. W., Xu, L., Li, J. Q., Pan, X., Zhu, M., Chen, X. H., Sun, A. J., Lin, J. R., & Gao, P. J. (2024). Activation of β3-adrenergic receptor by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue. Cardiovascular Research, 120(17), 2307-2319. https://doi.org/10.1093/cvr/cvae213

Vancouver

Zhang ZB, Cheng YW, Xu L, Li JQ, Pan X, Zhu M, et al. Activation of β3-adrenergic receptor by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue. Cardiovascular Research. 2024;120(17):2307-2319. doi:10.1093/cvr/cvae213

BibTeX
@article{Zhang2024,
  author = {Zhang, Ze-Bei and Cheng, Yu-Wen and Xu, Lian and Li, Jia-Qi and Pan, Xin and Zhu, Min and Chen, Xiao-Hui and Sun, Ai-Jun and Lin, Jing-Rong and Gao, Ping-Jin},
  title = {Activation of β3-adrenergic receptor by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {17},
  pages = {2307--2319},
  doi = {10.1093/cvr/cvae213}
}
Kostenlos starten →